title: Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells.
authors.forename: C
authors.initials: C
authors.lastname: Preisinger
authors.forename: J P
authors.initials: JP
authors.lastname: Schwarz
authors.forename: O B
authors.initials: OB
authors.lastname: Bleijerveld
authors.forename: E
authors.initials: E
authors.lastname: Corradini
authors.forename: P J
authors.initials: PJ
authors.lastname: Müller
authors.forename: K I
authors.initials: KI
authors.lastname: Anderson
authors.forename: W
authors.initials: W
authors.lastname: Kolch
authors.forename: A
authors.initials: A
authors.lastname: Scholten
authors.forename: A J R
authors.initials: AJ
authors.lastname: Heck
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D001752:Blast Crisis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002462:Cell Membrane / Q000378:metabolism; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D047468:Immunoprecipitation; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010766:Phosphorylation / Q000187:drug effects; D019000:Phosphotyrosine / Q000032:analysis / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D014407:Tumor Cells, Cultured; D014443:Tyrosine / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D000970:Antineoplastic Agents; D001549:Benzamides; C490895:GAB2 protein, human; D010879:Piperazines; D011743:Pyrimidines; D019000:Phosphotyrosine; D014443:Tyrosine; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl